Screening for prolactin receptor could help improve TNBC prognosis and treatment

[News]

A study conducted at the Research Institute of the McGill University Health Centre suggests screening breast cancer patients for the prolactin receptor could improve the prognosis for patient and may help them avoid unnecessary and invasive treatments

More... (http://www.news-medical.net/news/20161024/Screening-for-prolactin-receptor-could-help-improve-TNBC-prognosis-and-treatment.aspx)